Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Shares Outstanding (Diluted Average) (2022 - 2025)

Lucid Diagnostics filings provide 4 years of Shares Outstanding (Diluted Average) readings, the most recent being $92.1 million for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 82.89% to $92.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $92.1 million, a 82.89% increase, with the full-year FY2024 number at $50.5 million, up 20.98% from a year prior.
  • Shares Outstanding (Diluted Average) hit $92.1 million in Q3 2025 for Lucid Diagnostics, down from $99.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $99.0 million in Q2 2025 to a low of $35.4 million in Q2 2022.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $43.4 million (2023), compared with a mean of $52.0 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 9.87% in 2024 and later skyrocketed 105.32% in 2025.
  • Lucid Diagnostics' Shares Outstanding (Diluted Average) stood at $36.2 million in 2022, then grew by 15.44% to $41.8 million in 2023, then increased by 20.98% to $50.5 million in 2024, then soared by 82.38% to $92.1 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $92.1 million (Q3 2025), $99.0 million (Q2 2025), and $68.8 million (Q1 2025) per Business Quant data.